SitesBLAST
Comparing Echvi_0577 FitnessBrowser__Cola:Echvi_0577 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 20 (the maximum) hits to proteins with known functional sites (download)
P04181 Ornithine aminotransferase, mitochondrial; Ornithine delta-aminotransferase; Ornithine--oxo-acid aminotransferase; EC 2.6.1.13 from Homo sapiens (Human) (see 8 papers)
61% identity, 98% coverage: 7:411/413 of query aligns to 39:439/439 of P04181
- G51 (= G19) to D: in HOGA; loss of protein stability; loss of ornithine aminotransferase activity; dbSNP:rs11553554
- Y55 (= Y23) to H: in HOGA; decreased protein abundance; dbSNP:rs121965037
- N89 (= N57) to K: in HOGA; no effect on protein abundance; dbSNP:rs386833602
- Q90 (= Q58) to E: in HOGA; mistargeted, accumulates in cytoplasm; dbSNP:rs121965060
- C93 (= C61) to F: in HOGA; no effect on protein abundance; dbSNP:rs121965038
- Q104 (= Q72) to R: in HOGA; loss of protein stability; loss of ornithine aminotransferase activity; dbSNP:rs386833604
- R154 (= R122) to L: in HOGA; no effect on protein abundance; loss of ornithine aminotransferase activity; dbSNP:rs121965039
- R180 (= R148) to T: in HOGA; no effect on protein abundance; loss of ornithine aminotransferase activity; dbSNP:rs121965040
- A184 (≠ V152) natural variant: Missing (in HOGA; no effect on protein abundance; loss of ornithine aminotransferase activity; dbSNP:rs121965035)
- P199 (= P167) to Q: in HOGA; loss of protein stability; loss of ornithine aminotransferase activity; dbSNP:rs267606925
- A226 (≠ G195) to V: in HOGA; loss of protein stability; loss of ornithine aminotransferase activity; dbSNP:rs121965059
- P241 (= P210) to L: in HOGA; no effect on protein abundance; dbSNP:rs121965051
- Y245 (= Y214) to C: in HOGA; no effect on protein abundance; dbSNP:rs121965046
- R250 (≠ A219) to P: in HOGA; no effect on protein abundance; dbSNP:rs121965052
- T267 (= T236) to I: in HOGA; decreased protein abundance; dbSNP:rs386833618
- A270 (= A239) to P: decreased protein abundance; dbSNP:rs121965041
- R271 (= R240) to K: in HOGA; no effect on protein abundance; loss of ornithine aminotransferase activity; dbSNP:rs121965042
- K292 (= K261) modified: N6-(pyridoxal phosphate)lysine
- E318 (≠ Q287) to K: in HOGA; loss of protein stability; loss of ornithine aminotransferase activity; dbSNP:rs386833621
- V332 (= V301) to M: in HOGA; loss of protein stability; loss of ornithine aminotransferase activityx; dbSNP:rs121965047
- G353 (= G322) to D: in HOGA; decreased protein abundance; dbSNP:rs121965053
- G375 (= G346) to A: in HOGA; decreased protein abundance; dbSNP:rs121965045
- C394 (= C366) to R: in HOGA; no effect on protein abundance; dbSNP:rs121965054; to Y: in HOGA; loss of protein stability; loss of ornithine aminotransferase activity; dbSNP:rs386833597
- L402 (= L374) to P: in HOGA; may affect protein stability; loss of ornithine aminotransferase activity; dbSNP:rs121965043
- P417 (= P389) to L: in HOGA; loss of protein stability; loss of ornithine aminotransferase activity; dbSNP:rs121965044
- I436 (= I408) to N: in HOGA; loss of protein stability; loss of ornithine aminotransferase activity; dbSNP:rs386833598
- L437 (≠ Q409) to F: in HOGA; no effect on protein stability; increased ornithine aminotransferase activity; dbSNP:rs1800456
Sites not aligning to the query:
- 1:35 modified: transit peptide, Mitochondrion; in renal form
7ta0A Human ornithine aminotransferase (hoat) soaked with 5-aminovaleric acid (see paper)
61% identity, 98% coverage: 7:411/413 of query aligns to 3:403/403 of 7ta0A
- binding 5-[({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)amino]pentanoic acid: Y19 (= Y23), Y49 (= Y53), G106 (= G110), V107 (≠ A111), F141 (= F145), W142 (≠ H146), D227 (= D232), I229 (= I234), Q230 (= Q235), K256 (= K261), S285 (= S290), T286 (= T291)
8ez1B Human ornithine aminotransferase (hoat) co-crystallized with its inactivator 3-amino-4-fluorocyclopentenecarboxylic acid (see paper)
61% identity, 98% coverage: 7:411/413 of query aligns to 2:402/402 of 8ez1B
- binding (1R,3S,4Z)-3-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)-4-iminocyclopentane-1-carboxylic acid: Y48 (= Y53), T104 (= T109), G105 (= G110), V106 (≠ A111), F140 (= F145), W141 (≠ H146), E198 (= E204), D226 (= D232), I228 (= I234), Q229 (= Q235), K255 (= K261), R376 (= R385)
8ez1A Human ornithine aminotransferase (hoat) co-crystallized with its inactivator 3-amino-4-fluorocyclopentenecarboxylic acid (see paper)
61% identity, 98% coverage: 7:411/413 of query aligns to 2:402/402 of 8ez1A
- binding (3E,4E)-4-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methylidene)-3-iminocyclopent-1-ene-1-carboxylic acid: Y48 (= Y53), G105 (= G110), V106 (≠ A111), F140 (= F145), W141 (≠ H146), E198 (= E204), D226 (= D232), I228 (= I234), Q229 (= Q235), K255 (= K261), R376 (= R385)
7tfpC Human ornithine aminotransferase cocrystallized with its inhibitor, (1s,3s)-3-amino-4-(difluoromethylene)cyclopentane-1-carboxylic acid. (see paper)
61% identity, 98% coverage: 7:411/413 of query aligns to 2:402/402 of 7tfpC
- binding (1S,3S,4S)-3-amino-4-(fluoromethyl)cyclopentane-1-carboxylic acid: Y18 (= Y23), Y48 (= Y53), F140 (= F145), E198 (= E204), K255 (= K261), R376 (= R385)
- binding pyridoxal-5'-phosphate: G105 (= G110), V106 (≠ A111), F140 (= F145), W141 (≠ H146), D226 (= D232), I228 (= I234), Q229 (= Q235), K255 (= K261)
7lk0A Ornithine aminotransferase (oat) cocrystallized with its potent inhibitor - (s)-3-amino-4,4-difluorocyclopent-1-enecarboxylic acid (ss-1-148) (see paper)
61% identity, 98% coverage: 7:411/413 of query aligns to 2:402/402 of 7lk0A
- binding (1R,3S)-3-[(E)-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methylidene)amino]-4-oxocyclopentane-1-carboxylic acid: Y18 (= Y23), Y48 (= Y53), G105 (= G110), V106 (≠ A111), F140 (= F145), W141 (≠ H146), E198 (= E204), D226 (= D232), I228 (= I234), Q229 (= Q235), K255 (= K261)
7jx9A The crystal structure of human ornithine aminotransferase with an intermediate bound during inactivation by (1s,3s)-3-amino-4- (hexafluoropropan-2-ylidenyl)-cyclopentane-1-carboxylic acid. (see paper)
61% identity, 98% coverage: 7:411/413 of query aligns to 2:402/402 of 7jx9A
- active site: F140 (= F145), E193 (= E199), D226 (= D232), Q229 (= Q235), K255 (= K261), T285 (= T291), R376 (= R385)
- binding (1S,3S,4S)-3-[(E)-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methylidene)amino]-4-(1,1,3,3,3-pentafluoroprop-1-en-2-yl)cyclopentane-1-carboxylic acid: Y18 (= Y23), Y48 (= Y53), G105 (= G110), V106 (≠ A111), F140 (= F145), W141 (≠ H146), E198 (= E204), D226 (= D232), I228 (= I234), Q229 (= Q235), K255 (= K261), R376 (= R385)
- binding N-[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]glycine: S149 (= S154), F163 (≠ Y168), M164 (≠ T169), P165 (= P170), F167 (= F172), R180 (≠ D185), A181 (≠ V186)
6v8dA Design, synthesis, and mechanism of fluorine-substituted cyclohexene analogues of gama-aminobutyric acid (gaba) as selective ornithine aminotransferase inactivators
61% identity, 98% coverage: 7:411/413 of query aligns to 2:402/402 of 6v8dA
- active site: F140 (= F145), E193 (= E199), D226 (= D232), Q229 (= Q235), K255 (= K261), T285 (= T291), R376 (= R385)
- binding (3Z)-3-iminocyclohex-1-ene-1-carboxylic acid: Y48 (= Y53), K255 (= K261)
- binding pyridoxal-5'-phosphate: T104 (= T109), G105 (= G110), V106 (≠ A111), W141 (≠ H146), D226 (= D232), I228 (= I234), Q229 (= Q235), K255 (= K261)
2canA Human ornithine aminotransferase complexed with l-canaline (see paper)
61% identity, 98% coverage: 7:411/413 of query aligns to 2:402/402 of 2canA
- active site: F140 (= F145), E193 (= E199), D226 (= D232), Q229 (= Q235), K255 (= K261), T285 (= T291), R376 (= R385)
- binding canaline: Y18 (= Y23), F140 (= F145), R143 (= R148), G283 (= G289), S284 (= S290)
- binding pyridoxal-5'-phosphate: G105 (= G110), V106 (≠ A111), F140 (= F145), W141 (≠ H146), D226 (= D232), I228 (= I234), Q229 (= Q235), K255 (= K261)
1gbnB Human ornithine aminotransferase complexed with the neurotoxin gabaculine (see paper)
61% identity, 98% coverage: 7:411/413 of query aligns to 2:402/402 of 1gbnB
- active site: F140 (= F145), E193 (= E199), D226 (= D232), Q229 (= Q235), K255 (= K261), T285 (= T291), R376 (= R385)
- binding gabaculine: Y18 (= Y23), Y48 (= Y53), F140 (= F145), E198 (= E204), K255 (= K261)
- binding pyridoxal-5'-phosphate: G105 (= G110), V106 (≠ A111), F140 (= F145), W141 (≠ H146), D226 (= D232), I228 (= I234), K255 (= K261)
1gbnA Human ornithine aminotransferase complexed with the neurotoxin gabaculine (see paper)
61% identity, 98% coverage: 7:411/413 of query aligns to 2:402/402 of 1gbnA
- active site: F140 (= F145), E193 (= E199), D226 (= D232), Q229 (= Q235), K255 (= K261), T285 (= T291), R376 (= R385)
- binding 3-aminobenzoic acid: Y18 (= Y23), Y48 (= Y53), E198 (= E204), K255 (= K261)
- binding pyridoxal-5'-phosphate: G105 (= G110), V106 (≠ A111), F140 (= F145), W141 (≠ H146), D226 (= D232), I228 (= I234), K255 (= K261)
7tedA Human ornithine aminotransferase cocrystallized with its inhibitor, (s,e)-3-amino-4-(fluoromethylene)cyclopent-1-ene-1-carboxylate (see paper)
61% identity, 98% coverage: 7:411/413 of query aligns to 4:404/404 of 7tedA
- binding (1S,3R,4S)-3-formyl-4-[({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)amino]cyclopentane-1-carboxylic acid: Y20 (= Y23), Y50 (= Y53), G107 (= G110), V108 (≠ A111), F142 (= F145), W143 (≠ H146), G144 (= G147), E200 (= E204), D228 (= D232), I230 (= I234), Q231 (= Q235), K257 (= K261), S286 (= S290), T287 (= T291)
7ta1A Human ornithine aminotransferase (hoat) soaked with gamma-aminobutyric acid (see paper)
61% identity, 98% coverage: 7:411/413 of query aligns to 4:404/404 of 7ta1A
7lnmB Ornithine aminotransferase (oat) cocrystallized with its inactivator - (1s,3s)-3-amino-4-(difluoromethylene)cyclopentene-1-carboxylic acid (see paper)
61% identity, 98% coverage: 7:411/413 of query aligns to 4:404/404 of 7lnmB
- binding (1~{R},3~{S},4~{R})-3-methyl-4-[[2-methyl-3-oxidanyl-5-(phosphonooxymethyl)pyridin-4-yl]methylamino]cyclopentane-1-carboxylic acid: Y50 (= Y53), G107 (= G110), V108 (≠ A111), F142 (= F145), W143 (≠ H146), D228 (= D232), I230 (= I234), Q231 (= Q235), K257 (= K261)
7lk1A Ornithine aminotransferase (oat) with its potent inhibitor - (s)-3- amino-4,4-difluorocyclopent-1-enecarboxylic acid (ss-1-148) - 1 hour soaking (see paper)
61% identity, 98% coverage: 7:411/413 of query aligns to 4:404/404 of 7lk1A
- binding (1R,4R)-4-fluoro-3-[({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)amino]cyclopent-2-ene-1-carboxylic acid: Y50 (= Y53), G107 (= G110), V108 (≠ A111), F142 (= F145), W143 (≠ H146), E200 (= E204), D228 (= D232), I230 (= I234), Q231 (= Q235), K257 (= K261), R378 (= R385)
6v8cA Design, synthesis, and mechanism of fluorine-substituted cyclohexene analogues of gama-aminobutyric acid (gaba) as selective ornithine aminotransferase inactivators
61% identity, 98% coverage: 7:411/413 of query aligns to 4:404/404 of 6v8cA
- active site: F142 (= F145), E195 (= E199), D228 (= D232), Q231 (= Q235), K257 (= K261), T287 (= T291), R378 (= R385)
- binding pyridoxal-5'-phosphate: G107 (= G110), V108 (≠ A111), F142 (= F145), W143 (≠ H146), D228 (= D232), I230 (= I234), K257 (= K261)
- binding 3-aminocyclohexa-1,3-diene-1-carboxylic acid: Y20 (= Y23), Y50 (= Y53), F142 (= F145), K257 (= K261)
6oiaA (1s,3s)-3-amino-4-(perfluoropropan-2-ylidene)cyclopentane-1-carboxylic acid hydrochloride, a potent inhibitor of ornithine aminotransferase (see paper)
61% identity, 98% coverage: 7:411/413 of query aligns to 4:404/404 of 6oiaA
- active site: F142 (= F145), E195 (= E199), D228 (= D232), Q231 (= Q235), K257 (= K261), T287 (= T291), R378 (= R385)
- binding (1S)-3-amino-4-[(2S)-1,1,1-trifluoro-3-oxopropan-2-yl]cyclopent-3-ene-1-carboxylic acid: S286 (= S290), T287 (= T291)
- binding pyridoxal-5'-phosphate: G107 (= G110), V108 (≠ A111), F142 (= F145), W143 (≠ H146), D228 (= D232), I230 (= I234), K257 (= K261)
5vwoA Ornithine aminotransferase inactivated by (1r,3s,4s)-3-amino-4- fluorocyclopentane-1-carboxylic acid (fcp) (see paper)
61% identity, 98% coverage: 7:411/413 of query aligns to 4:404/404 of 5vwoA
- active site: F142 (= F145), E195 (= E199), D228 (= D232), Q231 (= Q235), K257 (= K261), T287 (= T291), R378 (= R385)
- binding (1S,3S,4E)-3-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)-4-iminocyclopentane-1-carboxylic acid: Y50 (= Y53), G107 (= G110), V108 (≠ A111), F142 (= F145), W143 (≠ H146), G144 (= G147), R145 (= R148), E200 (= E204), D228 (= D232), I230 (= I234), Q231 (= Q235), K257 (= K261)
2oatA Ornithine aminotransferase complexed with 5-fluoromethylornithine (see paper)
61% identity, 98% coverage: 7:411/413 of query aligns to 4:404/404 of 2oatA
- active site: F142 (= F145), E195 (= E199), D228 (= D232), Q231 (= Q235), K257 (= K261), T287 (= T291), R378 (= R385)
- binding 1-amino-7-(2-methyl-3-oxido-5-((phosphonoxy)methyl)-4-pyridoxal-5-oxo-6-heptenate: Y20 (= Y23), G107 (= G110), V108 (≠ A111), F142 (= F145), W143 (≠ H146), R145 (= R148), E195 (= E199), E200 (= E204), D228 (= D232), Q231 (= Q235), K257 (= K261), G285 (= G289), T287 (= T291)
2byjA Ornithine aminotransferase mutant y85i (see paper)
60% identity, 98% coverage: 7:411/413 of query aligns to 4:404/404 of 2byjA
- active site: F142 (= F145), E195 (= E199), D228 (= D232), Q231 (= Q235), K257 (= K261), T287 (= T291), R378 (= R385)
- binding pyridoxal-5'-phosphate: G107 (= G110), V108 (≠ A111), F142 (= F145), W143 (≠ H146), D228 (= D232), I230 (= I234), Q231 (= Q235), K257 (= K261)
Query Sequence
>Echvi_0577 FitnessBrowser__Cola:Echvi_0577
MMQPITSSQQAIELENKHGAHNYHPLPVVLSRGEGVFMWDVEGEKYYDFLSSYSAVNQGH
CHPRILQTLIDQAGTLTLTSRAFHNDVLGPFEKFLTEYFGYDKVLPMNTGAEGVETAIKI
ARKWGYEKKGIPENEGTIIVAKNNFHGRTTTVISFSNDETARKNFGPYTPGFVTIPHDDI
DALKDVLSQSKNIIGYLVEPIQGEAGVYVPKEGYLKEVAAVCKDHGVLFMADEIQTGIAR
TGKLLACDHEGVKPDMLILGKAISGGFYPVSAVLADDHIMEVIQPGQHGSTFGGNPLGAK
VAMTALNVVKDEKLAENADKLGKLFRERIQQLVDKSDLVELVRGKGLLNAIVINDTEDSD
TAWRLCLALKENGLLAKPTHGNIIRFAPPLVITEEQLHDCCDIIEKTIQNFKK
Or try a new SitesBLAST search
SitesBLAST's Database
SitesBLAST's database includes
(1) SwissProt
entries with experimentally-supported functional features;
and (2) protein structures with bound ligands, from the
BioLip database.
by Morgan Price,
Arkin group
Lawrence Berkeley National Laboratory